MAJOR AND SWEEPING CHANGES PLANNED FOR FDA (Orthopedics This Week)
Like the British navy sailing to the Falkland Islands, the Food and Drug Administration (FDA) has been signaling that big changes are afoot in 2014 in how the agency will be reorganized.
In late 2013, the agency announced it would need to “realign” its programs to keep up with “unparalleled challenges” posed by advances in science, globalization and product complexity.
On February 4, 2014, Regulatory Focus writer Alexander Gaffney reported that FDA Commissioner Margaret Hamburg, M.D. has unveiled major and sweeping changes to t...
